SEQL Stock Overview
SeqLL Inc. operates as a life sciences instrumentation and research services company worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
SeqLL Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$1.80 |
| 52 Week High | US$35.36 |
| 52 Week Low | US$1.40 |
| Beta | 0.65 |
| 1 Month Change | -43.75% |
| 3 Month Change | -59.98% |
| 1 Year Change | -89.64% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -99.01% |
Recent News & Updates
Recent updates
Shareholder Returns
| SEQL | US Life Sciences | US Market | |
|---|---|---|---|
| 7D | 0.7% | -4.9% | -3.7% |
| 1Y | -89.6% | -4.3% | 20.5% |
Return vs Industry: SEQL underperformed the US Life Sciences industry which returned -6.3% over the past year.
Return vs Market: SEQL underperformed the US Market which returned 20.2% over the past year.
Price Volatility
| SEQL volatility | |
|---|---|
| SEQL Average Weekly Movement | 30.7% |
| Life Sciences Industry Average Movement | 7.0% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.4% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: SEQL's share price has been volatile over the past 3 months.
Volatility Over Time: SEQL's weekly volatility has increased from 22% to 31% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2013 | 7 | Dan Jones | seqll.com |
SeqLL Inc. operates as a life sciences instrumentation and research services company worldwide. It focus on development of scientific assets and novel intellectual property across multiple omics fields. The company’s True Single Molecule Sequencing technology (tSMS) platform offers a single molecule solution for DNA and RNA sequencing through detection of nucleic acids to researchers for analyzing many billions of single molecules in a single experiment and generate accurate and reproducible data.
SeqLL Inc. Fundamentals Summary
| SEQL fundamental statistics | |
|---|---|
| Market cap | US$685.17k |
| Earnings (TTM) | -US$5.63m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-0.1x
P/E RatioIs SEQL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SEQL income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$5.63m |
| Earnings | -US$5.63m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -14.78 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 226.2% |
How did SEQL perform over the long term?
See historical performance and comparison